Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Endometriosis
|
274 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Autoimmune Diseases
|
428 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.020 | 1.000 | 2 | 2013 | 2013 | ||||||
Vitiligo
|
249 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.020 | 1.000 | 2 | 2013 | 2013 | ||||||
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)
|
92 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.020 | 1.000 | 2 | 2013 | 2013 | ||||||
Non-Small Cell Lung Carcinoma
|
712 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Systemic Scleroderma
|
287 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1 | 2013 | 2013 | |||||||
Colorectal Carcinoma
|
1962 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Triple Negative Breast Neoplasms
|
99 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Triple-Negative Breast Carcinoma
|
96 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Acute Chest Syndrome
|
135 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.020 | 1.000 | 2 | 2013 | 2016 | ||||||
Chronic kidney disease stage 5
|
194 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Cytomegalovirus Infections
|
26 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Graft-vs-Host Disease
|
25 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1 | 2016 | 2016 | |||||||
Hepatic Veno-Occlusive Disease
|
2 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Kidney Failure, Chronic
|
425 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Allergic rhinitis (disorder)
|
176 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.030 | 0.667 | 3 | 2011 | 2017 | ||||||
Autism Spectrum Disorders
|
331 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1 | 2017 | 2017 | |||||||
Pemphigus Foliaceus
|
16 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Psoriasis
|
705 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1 | 2017 | 2017 | |||||||
Neoplasms
|
1644 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.020 | 1.000 | 2 | 2014 | 2018 | ||||||
Tumor Progression
|
72 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.020 | 1.000 | 2 | 2014 | 2018 | ||||||
Degenerative polyarthritis
|
247 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Endometrial Carcinoma
|
326 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site
|
24 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 |